Women's Health

Results from the 12-week clinical trial link a targeted probiotic formula to measurable improvements in menopausal symptoms and quality of life.

In this interview, Mark LeDoux, Chairman and CEO of NAI, explains what brands need to know about marketing for female demographics and the broader applications of performance ingredients.

The brand has partnered with the Society for Women's Health Research to open conversations around menopause, hormone, and wellness knowledge gaps.

The unchanged formula, containing a bioactive form of folate, now carries banned-substance testing.

A new randomized, placebo-controlled trial examined the combined botanical's effects, finding support for hot flashes, sleep, mood, and hormone levels.

A precision-fermented, low-iron lactoferrin is now commercially available at scale in the United States, with research showing its effects vary by pathogen and mechanism.

A new six-month study of 180 women found tailored hair growth nutraceuticals significantly increased linear hair growth rate, anagen hair counts, and scalp coverage.

Explore the market growth, life-stage needs, and physiological benefits of creatine for women.

The SciComms Connect event addresses translating women’s research into compliant and substantiated dietary supplement claims.

A randomized controlled trial reports that a low-dose saffron extract improved mood, sleep-related impairment, and self-esteem scores in women aged 50 to 70, adding a multidimensional angle to a body of research that has focused largely on depressive symptoms alone.

At The Outlook on Women's Wellness, Ayla Barmmer explained how ovarian health was about so much more than fertility and menopause, and is actually connected to women's overall health, and longevity.

At The Outlook on Women's Wellness conference, Dr. Julie Russak laid out the clinical evidence tiers behind nutricosmetic ingredients, the biological case for an inside-out approach, and why she believes the next decade of skin longevity science will be built around a concept she calls "skinspan."

Tracing ingredients from sourcing through testing supports clean-label claims and customer confidence in finished products.

At The Outlook on Women’s Wellness, Jennifer Greer, ND, Med, explained how functional botanicals address sleep, mood, and metabolism for menopausal transition phases.

At The Outlook on Women’s Wellness, Stacey Smith, DC, discussed formulating women's supplements using the gut-vaginal axis, community state types, and resilient yeast-based probiotics.

In the keynote presentation for The Outlook on Women’s Wellness, Amanda Frick, ND, LAc shared strategies for supplement brands to address clinical gaps in menopause support.

The systematic review noted beta-alanine consistently delays fatigue in female athletes.

From S-equol to bioactive collagen peptides, a session at The Outlook on Women's Wellness conference mapped the clinical evidence and practical formulation considerations for a growing class of bone-supportive ingredients.

Learn how the official rename of the condition opens new opportunities for nutraceutical brands targeting systemic metabolic wellness.

Clinical research, botanical innovation, and targeted delivery formats are reshaping the menopause supplement market as nutraceutical companies develop science-backed solutions for sleep, muscle health, and women’s wellness.

Women’s health is undergoing a renaissance. Scientists and manufacturers are finally recognizing the critical need for research and product innovations that truly represent women and their actual needs. In honor of Women’s Health Month, Nutritional Outlook is spotlighting the science, innovations, and leaders driving progress in the women's health category.

From mitochondrial health and omega-3s to PMOS, botanicals, and preconception nutrition, emerging research is reshaping how the natural products industry approaches fertility and women’s health.

Dr. Thais Aliabadi, OBGYN, explains why the renaming of PCOS to PMOS is vital for addressing the root metabolic, endocrine, and whole-body health symptoms women face.

In an interview with Nutritional Outlook, Sameena Rahman, MD, a board-certified OB/GYN, discusses why the shift from Polycystic Ovary Syndrome to Polyendocrine Metabolic Ovarian Syndrome reflects growing recognition of the condition’s links to insulin resistance, inflammation, cardiovascular risk, and lifelong metabolic health.

From hormonal wellness and sports recovery to delivery technologies and Ayurvedic positioning, fenugreek is gaining attention across multiple women’s health categories as manufacturers explore multifunctional botanical formulations.